Boehringer Ingelheim Launches the First-Ever Registered Stem Cell-Based Veterinary Medicine
European Commission has granted marketing authorisation for the first stem cell-based product in animal health Arti-Cell® Forte is a unique…
Pharmaceuticals, Biotechnology and Life Sciences
European Commission has granted marketing authorisation for the first stem cell-based product in animal health Arti-Cell® Forte is a unique…
Expands Scientific Advisory Board with Appointment of Prof. David Spring CAMBRIDGE, England–(BUSINESS WIRE)–Nanna Therapeutics Ltd, a biotechnology company developing novel…
Imeglimin Phase 3 trial (TIMES 1) met its primary and main secondary endpoints Imeglimin Phase 3 TIMES 3 16-week, double-blind,…
Immediate access to UK medical cannabis market LONDON–(BUSINESS WIRE)–EMMAC Life Sciences Ltd (“EMMAC” or the “Company”), the European independent medical…
Expanded license creates opportunity for vadadustat to be provided to up to 60% of U.S. dialysis patients, subject to FDA…
Expanded licence creates opportunity for vadadustat to be provided to up to 60% of U.S. dialysis patients, subject to FDA…
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will issue a press release on its…
Bio-Rad has bagged clearance from the U.S. Food and DrugAdministration (FDA) for its IH-500, an automated randomaccess system for blood typing and screening.
The U.S. Food and Drug Administration Monday approved Dovato, two-drug, fixed-dose, complete regimen for HIV-infected adults who have never received treatment for HIV.
CINCINNATI–(BUSINESS WIRE)–Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2019 financial results after…